US Patent Issued to ABOLIS BIOTECHNOLOGIES on May 26 for "Recombinant yeast capable of producing caffeic acid and/or ferulic acid" (French Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,656, issued on May 26, was assigned to ABOLIS BIOTECHNOLOGIES (Evry, France).

"Recombinant yeast capable of producing caffeic acid and/or ferulic acid" was invented by Clementine Fojcik (Palaiseau, France), Andre Le Jeune (Draveil, France), Lorene Telot (Courcouronnes, France) and Cyril Saguez (Champlan, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a recombinant microorganism, preferably a recombinant yeast, capable of producing caffeic acid comprising a heterologous gene coding for an enzyme of the hydrolase family capable of breaking, preferably of hydrolyzing, the caffeoyl-shikimate bond to produce caffeic...